FDA approves new blood pressure and heart drug Sdamlo for adults and children.

The U.S. Food and Drug Administration has approved a new drug called Sdamlo (amlodipine) to treat high blood pressure (hypertension) in adults and children aged 6 years and older. It is also approved for adults with coronary artery disease, including chronic stable angina (chest pain), vasospastic angina, and coronary artery disease without heart failure or low ejection fraction. Sdamlo is a type of medicine called a calcium channel blocker. It works by relaxing blood vessels, which helps lower blood pressure and improve blood flow to the heart. The drug can be used alone or together with other blood pressure or heart medications. High blood pressure and coronary artery disease affect millions of people. Lowering blood pressure with Sdamlo can reduce the risk of serious events like stroke and heart attack. This approval provides an additional option for managing these conditions. However, it is important to remember that this is not a cure. Patients should talk to their doctor to see if Sdamlo is right for them and should not stop or change their current medicines without medical advice. Always follow your healthcare provider's instructions for managing your health.